Table 1.
Characteristics of Patients Hospitalized with Treatment-related Toxicity (N=117)
| Characteristic | No. of Patients | (%) |
|---|---|---|
| Age, years | ||
| Median | 67 | |
| Range | 21–93 | |
| No. of women | 69 | 59 |
| History of comorbidity | 44 | 38 |
| Cancer type | ||
| NHL | 27 | 23 |
| Colorectal cancer | 24 | 21 |
| Lung | 15 | 13 |
| Breast | 9 | 8 |
| Multiple myeloma | 8 | 7 |
| Esophagus | 6 | 5 |
| Other | 28 | 24 |
| Toxicity responsible for admission | ||
| Gastrointestinal | 44 | 38 |
| Infectious | 42 | 36 |
| Hematologic | 12 | 10 |
| Cardiac | 7 | 6 |
| Metabolic | 6 | 5 |
| Other | 6 | 5 |
| Treatment intent | ||
| Curative | 36 | 31 |
| Adjuvant | 24 | 30 |
| Palliative | 57 | 49 |
| Type of regimen | ||
| FU-based | 30 | 26 |
| Platinum-based* | 30 | 26 |
| CHOP | 24 | 21 |
| Oral | 8 | 7 |
| Other | 25 | 21 |
| Concurrent radiation | 10 | 9 |
Abbreviations: NHL, non-Hodgkin's lymphoma; FU,fluorouracil; CHOP, cyclophosphamide, adriamycin, vincristine, prednisone.
*
Includes 5 patients who received both FU and cisplatin.